Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoidsFiras Hamdan, Vincenzo Cerullo|Journal for ImmunoTherapy of Cancer|2021Cited by 53
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imagingSuvi Parviainen, Vincenzo Cerullo|Gene Therapy|2013Cited by 42
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenovirusesMichaela Feodoroff, Vincenzo Cerullo|OncoImmunology|2024Cited by 11
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapySalvatore Russo, Vincenzo Cerullo|Molecular Therapy Oncology|2024Cited by 6
Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine responseFiras Hamdan, Vincenzo Cerullo|Nature Communications|2026Cited by 4